A prospective clinical, scintigraphic, angiographic and functional evaluation of patients after inferior myocardial infarction with and without right ventricular dysfunction

To elucidate the functional and prognostic significance of right ventricular dysfunction after acute inferior wall myocardial infarction, 74 consecutive patients with inferior infarction were prospectively evaluated with gated equilibrium blood pool imaging at rest, submaximal exercise thallium-201 scintigraphy and coronary angiography before hospital discharge. In addition, symptom-limited stress thallium-201 scintigraphy was performed in 61 patients at 3 months, and all patients were followed up clinically for 23 +/- 15 months. Utilizing predetermined radionuclide angiographic criteria, 47 patients (Group I) had normal right ventricular function, 12 patients (Group II) had mild to moderate dysfunction and 15 patients (Group III) had severe right ventricular dysfunction. There were no significant differences among the groups with regard to age, history of prior myocardial infarction, peak creatine kinase values, maximal Killip functional class, number or type of in-hospital complications, left ventricular ejection fraction, prevalence of multivessel disease or the distribution and severity of disease affecting the infarct-related vessel. Exercise tolerance as assessed by treadmill time, blood pressure-heart rate product and peak work load in METS was comparable among the three groups, both before hospital discharge and at 3 month follow-up. No differences in indicators of exercise-induced ischemia were noted among the groups, including the prevalence of redistribution thallium-201 defects, ST segment depression or symptoms of chest pain. Finally, cardiac mortality, reinfarction rate and the incidence of medically refractory angina pectoris were similar in the three groups. Thus, right ventricular dysfunction after acute inferior wall myocardial infarction does not appear to limit exercise tolerance or identify a subgroup of patients at higher risk for recurrent cardiac events.

This article has been cited by other articles:

				K. A. Brown, G. V. Heller, R. S. Landin, L. J. Shaw, G. A. Beller, M. J. Pasquale, and S. B. Haber Early Dipyridamole 99mTc-Sestamibi Single Photon Emission Computed Tomographic Imaging 2 to 4 Days After Acute Myocardial Infarction Predicts In-Hospital and Postdischarge Cardiac Events : Comparison With Submaximal Exercise Imaging Circulation, November 16, 1999; 100(20): 2060 - 2066. [Abstract] [Full Text] [PDF]

				U. Zeymer, K.-L. Neuhaus, K. Wegscheider, U. Tebbe, P. Molhoek, R. Schroder, and for the HIT-4 Trial Group Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement J. Am. Coll. Cardiol., October 1, 1998; 32(4): 876 - 881. [Abstract] [Full Text] [PDF]